dp 522
Pill imprint dp 522 has been identified as Prochlorperazine maleate 10 mg.
Prochlorperazine is used in the treatment of nausea/vomiting; anxiety; psychosis; hiccups and belongs to the drug classes phenothiazine antiemetics, phenothiazine antipsychotics. Risk cannot be ruled out during pregnancy.
Prochlorperazine 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Prochlorperazine maleate Images
- Imprint:
-
dp
522 - Strength:
- 10 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Phenothiazine antiemetics
Phenothiazine antipsychotics - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0522
| NDC Code | Manufacturer / Repackager |
|---|---|
| 58016-0706 | Southwood Pharmaceuticals Inc (repackager) |
| 63874-0490 | Altura Pharmaceuticals Inc (repackager) |
| 55045-1126 | Dispensing Solutions Inc. (repackager) |
| 23490-6509 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Prochlorperazine Maleate resources
- Prochlorperazine (Wolters Kluwer)
- Prochlorperazine Suppositories (Wolters Kluwer)
- Prochlorperazine Syrup (Wolters Kluwer)
- Prochlorperazine Tablets (Wolters Kluwer)
- prochlorperazine (Cerner Multum)
- prochlorperazine rectal (Cerner Multum)
- Prochlorperazine (AHFS DI)
- Prochlorperazine Edisylate (AHFS DI)
- Prochlorperazine Maleate (AHFS DI)
- Prochlorperazine (FDA)
- Prochlorperazine Injection (FDA)
- Prochlorperazine Suppository (FDA)
- Prochlorperazine Tablets (FDA)
- Prochlorperazine (Wolters Kluwer)


